![Anders Larnholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 216 777 $ as of 2026-06-29
Anders Larnholt was the founder of Mallax Pharmaceuticals AB, serving as Head-Mergers & Acquisitions from 2020 to 2022.
Formerly, worked at Meda AB as VP-Corporate Development & Investor Relations from 2010 to 2013.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MedCap AB
 MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements 0.03% | 2026-02-08 | 4,000 ( 0.03% ) | 216 777 $ | 2026-06-29 |
| Companies | Position | End |
|---|---|---|
Mallax Pharmaceuticals AB
 Mallax Pharmaceuticals AB Financial ConglomeratesFinance Operates as investment company | Founder | 2022-11-30 |
| MEDA AB | Investor Relations Contact | 2013-11-25 |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Meda AB
 Meda AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Mallax Pharmaceuticals AB
Mallax Pharmaceuticals AB Financial ConglomeratesFinance Operates as investment company | Finance |
Select your edition
All financial news and data tailored to specific country editions
